Bupropion Hydrochloride 300 mg Extended Release Tablets Under Fasting Conditions
- First Posted Date
- 2010-01-11
- Last Posted Date
- 2015-11-20
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 8
- Registration Number
- NCT01046214
- Locations
- 🇺🇸
California Clinical Trials, Glendale, California, United States
Lansoprazole 30 mg DR Capsule Fasting Study
- First Posted Date
- 2010-01-11
- Last Posted Date
- 2010-12-08
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 56
- Registration Number
- NCT01045967
- Locations
- 🇺🇸
PRACS Institute, Ltd., Fargo, North Dakota, United States
Lansoprazole 30 mg DR Capsule Replicate Food Study
- First Posted Date
- 2010-01-11
- Last Posted Date
- 2010-12-08
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 50
- Registration Number
- NCT01046084
- Locations
- 🇺🇸
Gateway Medical Research, Inc., St. Charles, Missouri, United States
Lansoprazole 30 mg DR Capsule Fasting Replicate Sprinkle Study
- First Posted Date
- 2010-01-11
- Last Posted Date
- 2010-12-08
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 50
- Registration Number
- NCT01046253
- Locations
- 🇺🇸
Gateway Medical Research, Inc., St. Charles, Missouri, United States
Bioavailability of Metronidazole Vaginal Gel in Healthy Subjects
- First Posted Date
- 2009-11-26
- Last Posted Date
- 2010-06-29
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 38
- Registration Number
- NCT01020877
- Locations
- 🇺🇸
Novum Pharmaceutical Research Services, Pittsburgh, Pennsylvania, United States
Bioequivalence of Metronidazole Gel, 0.75% in the Treatment of Bacterial Vaginosis
- First Posted Date
- 2009-11-25
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 579
- Registration Number
- NCT01020396
- Locations
- 🇺🇸
Medical Affiliated Research Center, Inc., Huntsville, Alabama, United States
🇺🇸Office of Drs. Shepard and Lugerner, PC, Washington, District of Columbia, United States
🇺🇸Phoenix Ob-Gyn Associates, Mount Holly, New Jersey, United States
Divalproex Sodium 500 mg Extended Release Tablets Under Non-Fasting Conditions
- First Posted Date
- 2009-09-10
- Last Posted Date
- 2009-09-10
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 24
- Registration Number
- NCT00974012
- Locations
- 🇺🇸
PRACS Institute, Ltd., East Grand Forks, Minnesota, United States
Divalproex Sodium 500 mg Extended Release Tablets Under Fasting Conditions
- First Posted Date
- 2009-09-10
- Last Posted Date
- 2009-09-10
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 48
- Registration Number
- NCT00974441
- Locations
- 🇺🇸
PRACS Institute, Ltd., Fargo, North Dakota, United States
Study of Bicalutamide 1 x 50 mg Tablet in Healthy Subjects Under Fasting Conditions
- First Posted Date
- 2009-09-09
- Last Posted Date
- 2009-09-09
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 60
- Registration Number
- NCT00973050
- Locations
- 🇨🇦
Anapharm Inc., Sainte-Foy, Quebec, Canada
Study of Bicalutamide 1 x 50 mg Tablet in Healthy Subjects Under Fed Conditions
- First Posted Date
- 2009-09-09
- Last Posted Date
- 2009-09-09
- Lead Sponsor
- Teva Pharmaceuticals USA
- Target Recruit Count
- 60
- Registration Number
- NCT00972855
- Locations
- 🇨🇦
Anapharm Inc., Sainte-Foy, Quebec, Canada